Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study

Documenti analoghi

• Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
  di: Peeters, Stijn A, et al.
  Pubblicazione: (2015)
• Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study
  di: Engelen, Lian, et al.
  Pubblicazione: (2014)
• Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies
  di: Peeters, Stijn A., et al.
  Pubblicazione: (2017)
• Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study
  di: Gruden, Gabriella, et al.
  Pubblicazione: (2012)
• Anti–Heat Shock Protein 27 Antibody Levels and Diabetes Complications in the EURODIAB Study
  di: Burt, Davina, et al.
  Pubblicazione: (2009)